Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

News > Paris (region)

Please find below news from Paris as well as about organisations from the Paris region (Île-de-France).

Total search results: 1139 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Sanofi S.A.. (1/7/19). "Press Release: Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs". Paris & Tarrytown, NY. 2019-01-07
BioNTech AG. (1/4/19). "Press Release: Sanofi Invests EUR 80m (approx. USD 91.5m) in BioNTech as Partners Extend Collaboration and Advance mRNA-based Cancer Immunotherapy into Clinical Testing against Multiple Solid Tumors". Mainz. 2019-01-04
Novartis AG. (12/20/18). "Press Release: Novartis Announces Offer to Acquire CellforCure to Expand Manufacturing Capacity for Innovative Cell and Gene Therapies". Basel. 2018-12-20
Sanofi S.A.. (12/18/18). "Press Release: Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq". Paris. 2018-12-18
Protagen AG. (12/18/18). "Press Release: Protagen AG Appoints Immuno-Oncology Experts to Its Scientific Advisory Board". 2018-12-18
Carmat S.A.. (12/17/18). "Press Release: The European Investment Bank Supports Carmat with €30 Million for the Marketing Process of Its Total Artificial Heart". Paris. 2018-12-17
Kurma Partners. (12/14/18). "Press Release: Kurma Partners Announces the First Closing of Kurma Biofund III". Paris. 2018-12-14
Minoryx Therapeutics S.L.. (12/13/18). "Press Release: Minoryx Therapeutics Announces Early Completion of Patient Randomization in the ADVANCE Trial – a Phase 2/3 Clinical Study of MIN-102 in X-ALD Patients". Mataró, Barcelona. 2018-12-13
Carmat S.A.. (12/12/18). "Press Release: Carmat Announces the Appointment of Pascale d’Arbonneau as Chief Financial Officer". Paris. 2018-12-12
Abivax S.A.. (12/6/18). "Press Release: Abivax Receives DSMB Recommendation to Continue Ongoing Extension Study of Its Completed Phase 2a Clinical Trial in Ulcerative Colitis patients". Paris. 2018-12-06
L’Oréal S.A.. (12/5/18). "Press Release: L'Oréal Creates a Corporate Venture Capital Fund Dedicated to Accompanying Innovative Startups". Clichy. 2018-12-05
3B Pharmaceuticals GmbH. (11/20/18). "Press Release: Ipsen and 3BP Announce First Patient Dosed in Phase I/II Study for First-in-class Radionuclide (IPN01087)". Paris. 2018-11-20
Stilla Technologies S.A.S.. (11/20/18). "Press Release: Stilla Technologies Completes €16 Million ($18 Million) Series A". Paris. 2018-11-20
Ipsen S.A.. (11/15/18). "Press Release: European Commission Approves Ipsen’s Cabometyx (cabozantinib) for the Treatment of Hepatocellular Carcinoma in Adults Previously Treated with Sorafenib". Paris. 2018-11-15
IntegraGen S.A.. (11/12/18). "Press Release: IntegraGen Announces Collaboration with Google Cloud to Offer Large Scale Genomic Analysis Tools for Clinicians and Medical Researchers". Paris. 2018-11-12
Quantum Genomics S.A.. (11/12/18). "Press Release: Quantum Genomics Announces Excellent Topline Results from Phase 2b NEW-HOPE Study Evaluating Firibastat for Arterial Hypertension". Paris & New York, NY. 2018-11-12
Bone Therapeutics S.A.. (11/7/18). "Press Release: Bone Therapeutics Business Update for Third Quarter 2018". Gosselies. 2018-11-07
Denali Therapeutics Inc.. (11/1/18). "Press Release: Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors for the Treatment of Neurological and Inflammatory Diseases". South San Francisco, CA. 2018-11-01
Allogene Therapeutics, Inc.. (11/1/18). "Press Release: Allogene Therapeutics Announces Data Presentations Supporting Its Allogeneic CAR T Pipeline Program at 60th American Society of Hematology (ASH) Annual Meeting". South San Francisco, CA. 2018-11-01
Sanofi S.A.. (11/1/18). "Press Release: Sanofi and Denali Therapeutics to Develop Treatments for Neurological and Inflammatory Diseases". Paris. 2018-11-01
PathoQuest S.A.S.. (10/31/18). "Press Release: PathoQuest Achieves Illumina Propel Certification". 2018-10-31
Sanofi S.A.. (10/31/18). "Press Release: Sanofi Q3 2018 Performance Confirms Return to Growth". Paris. 2018-10-31
Microbiotica Ltd.. (10/24/18). "Press Release: Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital Fund". Cambridge. 2018-10-24
Magnisense SE. (10/24/18). "Press Release: Magnisense Successfully Raises € 5 Nillion to Boost the Commercial Development of Its MiAG Emergency Diagnostic Tests for Heart Diseases". Paris. 2018-10-24
Enterome S.A.. (10/23/18). "Press Release: Enterome Signs Global Licensing, Co-development and Co-Promotion Agreement with Takeda for the Treatment of Crohn’s Disease". Paris & Cambridge, MA. 2018-10-23
Hybrigenics S.A.. (10/23/18). "Press Release: Clinical Study of Inecalcitol in Acute Myeloid Leukemia Stopped for Futility. The Clinical Development of Inecalcitol Is Discontinued". Paris. 2018-10-23
Acticor Biotech. (10/17/18). "Press Release: Acticor Biotech Raises €15.3M in a Series B Financing". Paris. 2018-10-17
Sanofi S.A.. (10/16/18). "Press Release: Dupixent (dupilumab) Showed Positive Topline Results in Two Phase 3 trials of Patients with Chronic Rhinosinusitis with Nasal Polyps". Paris & Tarrytown, NY. 2018-10-16
Rgenix, Inc.. (10/9/18). "Press Release: Rgenix Raises $40M in Series C Funding To Support Clinical Stage Oncology Programs". New York, NY. 2018-10-09
Euronext N.V.. (10/8/18). "Press Release: Medincell Lists on Euronext Paris. €30 Million Raised, Market Capitalisation €144 Million". Paris. 2018-10-08
Evotec AG. (10/4/18). "Press Release: Evotec Signs Agreement with Sanofi to Advance Early Stage Academic Research into Novel Therapeutic Candidates". Hamburg. 2018-10-04
Sanofi S.A.. (10/1/18). "Press Release: Sanofi Completes Divestiture of Zentiva to Advent". Paris. 2018-10-01
Sanofi S.A.. (9/28/18). "Press Release: FDA Approves Libtayo (cemiplimab-rwlc) as First and Only Treatment for Advanced Cutaneous Squamous Cell Carcinoma". Paris & Tarrytown, NY. 2018-09-28
Novacyt S.A.. (9/26/18). "Press Release: Novacyt Half Year 2018 Results. Molecular Product Revenues up 18% to €3m – Gross Margin Increases to 64%". Paris & Camberley. 2018-09-26
PathoQuest S.A.S.. (9/25/18). "Press Release: PathoQuest Names Dr. Christiane Honisch to Board of Directors". Paris. 2018-09-25
genOway S.A.. (9/25/18). "Press Release: genOway Announces the Acquisition of Axenis to Create the Largest Offer of Preclinical Models in the Immuno-oncology and Immuno-inflammation Space". Lyon. 2018-09-25
Erytech Pharma. (9/20/18). "Press Release: Erytech Announces Enrollment of First Patients in Phase 3 Clinical Trial Evaluating Eryaspase for the Treatment of Second Line Pancreatic Cancer". Lyon & Cambridge, MA. 2018-09-20
Cellectis S.A.. (9/19/18). "Press Release: CAR-T Pioneer Dr. Stephan A. Grupp to Join Cellectis Clinical Advisory Board". New York, NY. 2018-09-19
GeNeuro S.A.. (9/18/18). "Press Release: GeNeuro Regains Worldwide Rights ex US and Japan to GNbAC1 in Multiple Sclerosis from Servier". Paris & Geneva. 2018-09-18
Horama S.A.. (9/18/18). "Press Release: Horama Completes Its 22.5 Million Euros Series B Financing Round". Paris. 2018-09-18
Sanofi S.A.. (9/15/18). "Press Release: Positive Phase 3 Results Presented for Dupixent (dupilumab) Show Significant Improvement on Multiple Measures of Disease Severity in Adolescents with Moderate-to-Severe Atopic Dermatitis". Paris & Tarrytown, NY. 2018-09-15
Sanofi S.A.. (9/13/18). "Press Release: Sanofi to Refocus Two Global Business Units". Paris. 2018-09-13
Neovacs S.A.. (9/11/18). "Press Release: Neovacs Announces that Its Partner Biosense Global Has Exercised Its Option to Acquire the Exclusive Licence for IFNalpha Kinoid to Treat Lupus in China". Paris & Boston, MA. 2018-09-11
Erytech Pharma. (9/10/18). "Press Release: Erytech Reports First Half of 2018 Financial Results and Provides Business Update". Lyon & Cambridge, MA. 2018-09-10
Allogene Therapeutics, Inc.. (9/6/18). "Press Release: Allogene Therapeutics Completes a $120 Million Private Financing". South San Francisco, CA. 2018-09-06
Sanofi S.A.. (9/4/18). "Press Release: Sanofi Reaches Civil Settlement with US SEC". Paris. 2018-09-04
Abivax S.A.. (9/4/18). "Press Release: Abivax Reports Impressive Results in Clinical Phase 2a Trial of ABX464 as an Oral Treatment for Ulcerative Colitis Patients". Paris. 2018-09-04
Sanofi S.A.. (9/3/18). "Press Release: Cablivi (caplacizumab) Approved in Europe for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. 2018-09-03
Onxeo S.A.. (7/27/18). "Press Release: Onxeo Reports Half-Year 2018 Financial Results and Provides Business Outlook". Paris. 2018-07-27
Nanobiotix S.A.. (7/26/18). "Press Release: Nanobiotix Signs a 40 M€ Non-dilutive Financing Agreement with the European Investment Bank". Paris & Cambridge, MA. 2018-07-26
Sanofi S.A.. (7/26/18). "Press Release: Sanofi Head of Human Resources Roberto Pucci to Retire, Company Names Caroline Luscombe to Take over October 1st". Paris. 2018-07-26
Abivax S.A.. (7/25/18). "Press Release: Abivax Secures up to EUR 20m Debt Financing from Kreos Capital". Paris. 2018-07-25
Revolution Medicines, Inc.. (7/18/18). "Press Release: Sanofi and Revolution Medicines Launch Global Partnership to Develop Potential First-in-Class Targeted Treatments for Multiple Cancers". Cambridge, MA & Redwood City, CA. 2018-07-18
Thermo Fisher Scientific Inc.. (7/17/18). "Press Release: New Thermo Scientific B•R•A•H•M•S PCT Direct Blood Test Allows Fast Bacterial Infection and Sepsis Diagnosis at Patient's Point of Care". Hennigsdorf. 2018-07-17
Antabio S.A.S.. (7/12/18). "Press Release: Antabio Completes € 12.5m Series A. New Investors Omnes, BNP Paribas Développement and Sham Innovation Santé Invest an Additional €5.2m". Labège. 2018-07-12
Thermo Fisher Scientific Inc.. (7/12/18). "Press Release: Thermo Scientific Krios Cryo-TEM Instrument Installed at the Institut Pasteur". Hillsboro, OR. 2018-07-12
PathoQuest S.A.S.. (7/10/18). "Press Release: PathoQuest Announces New Appointments to Executive Leadership Team". 2018-07-10
Yposkesi. (7/9/18). "Press Release: Yposkesi Appoints Dr. Fraser Wright as Senior Advisor". Corbeil-Essonnes. 2018-07-09
Dynacure S.A.S.. (7/6/18). "Press Release: Dynacure Secures €47 Million Financing to Advance Lead Program into Clinical Development". Strasbourg. 2018-07-06
Nextbiotix. (7/5/18). "Press Release: Nextbiotix Raises € 7m in a Series A Round to Tackle Inflammatory Bowel Diseases". Paris. 2018-07-05
Evotec AG. (7/3/18). "Press Release: Evotec Confirms Closing of Transaction with Sanofi to Accelerate Infectious Disease Research and Development". Hamburg. 2018-07-03
NuPharm Group. (7/3/18). "Press Release: NuPharm Group Announces the Acquisition of Laboratoire Biodim in France". Paris. 2018-07-03
Deinove S.A.. (6/28/18). "Press Release: Deinove Enters into Collaboration with bioMérieux to Discover New Antibiotics". Montpellier. 2018-06-28
Abivax S.A.. (6/25/18). "Press Release: Abivax Appoints Ian McGowan as Scientific Advisory Board Chair and Juergen Rockstroh as a New Member". Paris. 2018-06-25
NodThera Ltd.. (6/25/18). "Press Release: NodThera Secures £28 Million ($40 Million) Series A Financing". Cambridge. 2018-06-25
Evotec AG. (6/25/18). "Press Release: Evotec Achieves Second Milestone in Diabetes Alliance with Sanofi". Hamburg. 2018-06-25
TxCell S.A.. (6/21/18). "Press Release: First in Vivo Proof-of-Concept Data with CD8+ CAR-Treg Presented at FOCIS 2018". Valbonne. 2018-06-21
Nanobiotix S.A.. (6/21/18). "Press Release: Nanobiotix Announces Positive Phase II/III Topline Data in Soft Tissue Sarcoma with NBTXR3". Paris & Cambridge, MA. 2018-06-21
Sanofi S.A.. (6/19/18). "Press Release: Sanofi Appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer". Paris. 2018-06-19
Sanofi S.A.. (6/19/18). "Press Release: Sanofi Completes Its Acquisition of Ablynx Following the Expiration of the Squeeze-out Procedure". Paris & Ghent. 2018-06-19
Evotec AG. (6/18/18). "Press Release: Evotec and Sanofi Sign Definitive Agreement to Combat Infectious Disease". Hamburg. 2018-06-18
Deinove S.A.. (6/15/18). "Press Release: Successful Capital Increase €8.5 Million [Not for United States, Canada, Australia and Japan]". Montpellier. 2018-06-15
Cellnovo. (6/14/18). "Press Release: Cellnovo Announces the Commercialisation of Insulin Cartridges Following the Successful Start of Large-scale Manufacturing at the Flex Facility in Althofen, Austria". Paris. 2018-06-14
Medicen Paris Region. (6/14/18). "Press Release: Medicen Paris Region Appoints Stéphane Roques as CEO". Paris. 2018-06-14
Deinove S.A.. (6/14/18). "Press Release: Deinove Announces the Launch of a Capital Increase through an Accelerated Book Building [Not for United States, Canada, Australia and Japan]". Montpellier. 2018-06-14
Uniqure N.V.. (6/13/18). "Press Release: Uniqure Announces New Appointments to its Board of Directors". Lexington, MA & Amsterdam. 2018-06-13
Cellectis S.A.. (6/12/18). "Press Release: Cellectis Publishes Novel Methods to Improve the Clinical Use of Chimeric Antigen Receptor T-Cell Therapy in Scientific Reports". New York. 2018-06-12
Metafora Biosystems S.A.S.. (6/11/18). "Press Release: Metafora Biosystems Receives €3.2 Million from European Commission’s H2020 SME Instrument Program". Paris. 2018-06-11
Euronext N.V.. (5/30/18). "Press Release: Digital Biotech Voluntis Lists on Euronext". Paris. 2018-05-30
Adaptive Biotechnologies. (5/29/18). "Press Release: Adaptive Biotechnologies Announces a Collaboration With Sanofi to Use Adaptive’s clonoSEQ Assay to Measure Minimal Residual Disease in Active and Future Isatuximab Multiple Myeloma Trials". Seattle, WA 2018-05-29
Global Bioenergies S.A.. (5/15/18). "Press Release: Global Bioenergies Receives Three Additional Fundings from the European Union, further Supporting Its Strategy of Feedstock Diversification". Évry. 2018-05-15
Pierre Fabre S.A.. (5/14/18). "Press Release: Pierre Fabre Pharmaceuticals and the Start-up BioSerenity Join Forces to Develop the First Connected Fabric for the Detection and Medical Monitoring of Urinary Disorders". Castres. 2018-05-14
Cellectis S.A.. (5/7/18). "Press Release: Cellectis Reports 1st Quarter 2018 Financial Results". New York, NY. 2018-05-07
Pierre Fabre S.A.. (5/4/18). "Press Release: Pierre Fabre Group – Appointment of a New Chief Executive Officer". Castres. 2018-05-04
Cellectis S.A.. (5/2/18). "Press Release: Cellectis Files IND for UCART22 in Acute Lymphoblastic Leukemia (B-ALL)". New York, NY. 2018-05-02
Cellectis S.A.. (5/1/18). "Press Release: Harvard’s Wyss Institute Partners with Cellectis to Recode the Human Genome". Boston, MA & New York, NY. 2018-05-01
Crescendo Biologics Ltd.. (4/30/18). "Press Release: Crescendo Biologics Ltd. Raises $70 Million (€57 Million) in Series B Financing". Cambridge. 2018-04-30
A-Mansia Biotech S.A.. (4/27/18). "Press Release: Belgian Microbiome Spin-off A-Mansia Announces €13m First Close of Series A Financing". Louvain-la-Neuve. 2018-04-27
Sanofi S.A.. (4/27/18). "Press Release: First-quarter 2018 Business EPS up 1.4% at CER". Paris. 2018-04-27
Novacyt S.A.. (4/26/18). "Press Release: Novacyt Full Year 2017 Results". Paris & Camberley. 2018-04-26
TxCell S.A.. (4/25/18). "Press Release: TxCell – Financial Information for the 1st Quarter of 2018 and Availability of the 2017 Registration Document (document de référence)". Valbonne. 2018-04-25
Sanofi S.A.. (4/24/18). "Press Release: Sanofi Head of Global R&D Elias Zerhouni to Retire; Company Names John Reed to Take Over on July 1". Paris. 2018-04-24
EryDel S.p.A.. (4/24/18). "Press Release: EryDel Raises Euro 26.5 Million in Financing. Sofinnova Partners Leads Erydel’s Financing". Bresso. 2018-04-24
Onxeo S.A.. (4/24/18). "Press Release: Onxeo Announces Initiation of DRIIV Phase I Clinical Trial of AsiDNA for Treatment of Advanced Solid Tumor". Paris. 2018-04-24
Servier. (4/16/18). "Press Release: Servier Acquires Shire’s Oncology Business to Gain Direct Commercial Access in the US". Paris. 2018-04-16
Sofinnova Partners. (4/16/18). "Press Release: LimFlow Raises €27 million ($33.5 million) in Series C Financing Led by Sofinnova Partners to Advance Innovative Critical Limb Ischemia (CLI) treatment". Paris. 2018-04-16
Onxeo S.A.. (4/13/18). "Press Release: Onxeo Implements an Equity Line Financing Including an Incentive Program with Nice & Green SA. Cash for Operations Extended to Q3 2020". Montpellier. 2018-04-13
Deinove S.A.. (4/13/18). "Press Release: Deinove Takes on a Whole Dimension with the Acquisition of Morphochem’s Clinical-stage Antibiotic Compound". Montpellier. 2018-04-13
Luxinnovation. (4/10/18). "Press Release: A New Manager for Luxinnovation’s Luxembourg BioHealth Cluster". 2018-04-10
Cellectis S.A.. (4/10/18). "Press Release: Cellectis Announces Closing of Follow-on Offering". New York, NY. 2018-04-10
1 2 3 4 5 6 7 8 9 10 11 12  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top